Bleakley Financial Group, LLC Adma Biologics, Inc. Transaction History
Bleakley Financial Group, LLC
- $3.12 Trillion
- Q1 2025
A detailed history of Bleakley Financial Group, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 10,697 shares of ADMA stock, worth $192,546. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,697
Previous 16,739
36.1%
Holding current value
$192,546
Previous $287 Million
26.07%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ADMA
# of Institutions
378Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$336 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$303 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$232 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$206 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$102 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.53B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...